Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
0.63
-0.01 (-1.56%)
At close: Aug 22, 2025, 2:44 PM
0.63
0.00%
After-hours: Aug 22, 2025, 02:44 PM EDT
Brainstorm Cell Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 824K | 1.64M | 187K | 168K | 3.47M | 779K | 1.3M | 1.22M | 546K | 2.02M | 772K | 4.14M | 9.01M | 15.15M | 18.86M | 25.7M | 30.57M | 35.93M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 196K | 202K | 206K | 2.21M | 3.25M | 3.24M | 3.25M | 3.24M | 2.11M | 4.05M | 4.11M |
Long-Term Investments | n/a | 182K | 184K | 181K | 179K | 182K | 185K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 225K | 22K | 22K | 22K | 20K | 20K | 19K | 21K | 22K | 23K | 22.99K | 23K | 27K | 27K | 26.98K | 32K | 108K | 27K |
Receivables | 106K | 67K | 63K | 40K | 33K | 26K | 51K | 66K | 93K | 44K | 91K | 58K | 117K | 61K | 86K | 85K | 183K | 255K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17K | n/a | n/a | n/a | n/a |
Other Current Assets | 585K | 621K | 135K | n/a | 171K | 169K | 23K | 55K | 82K | 658K | 91K | n/a | n/a | 61K | n/a | n/a | n/a | n/a |
Total Current Assets | 1.51M | 2.33M | 385K | 364K | 3.82M | 1.26M | 1.9M | 1.54M | 1.21M | 2.93M | 3.11M | 7.5M | 12.81M | 19.26M | 23.28M | 27.94M | 35.19M | 41.03M |
Property-Plant & Equipment | 826K | 1.03M | 1.24M | 1.46M | 1.67M | 1.89M | 2.1M | 4.12M | 4.51M | 4.92M | 5.32M | 5.73M | 6.13M | 6.5M | 5.97M | 6.56M | 6.94M | 7.51M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | 3K | n/a | n/a | n/a | 9.00 | n/a | n/a | n/a | 17.00 | n/a | n/a | n/a |
Total Long-Term Assets | 1.05M | 1.24M | 1.45M | 1.66M | 1.87M | 2.09M | 2.31M | 4.14M | 4.53M | 4.94M | 5.34M | 5.75M | 6.16M | 6.53M | 6M | 6.59M | 7.05M | 7.54M |
Total Assets | 2.57M | 3.57M | 1.83M | 2.02M | 5.68M | 3.35M | 4.21M | 5.68M | 5.75M | 7.87M | 8.45M | 13.25M | 18.96M | 25.79M | 29.28M | 34.54M | 42.23M | 48.57M |
Account Payables | 6M | 6.8M | 6.08M | 4.6M | 5.34M | 4.69M | 4.95M | 3.93M | 5.19M | 7.8M | 6.22M | 6.39M | 5.29M | 4.57M | 3.7M | 2.74M | 3M | 2.55M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 101K | 1.2M | 300K | 570K | 566K | 588K | 603K | 1.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.74M | 2.04M | 2.3M |
Other Current Liabilities | 1.68M | 1.92M | 1.13M | 474K | 501K | 329K | 2.24M | -280K | n/a | 1.06M | 1.06M | n/a | 1.03M | 1.1M | n/a | -750K | -727K | -707K |
Total Current Liabilities | 8.53M | 10.9M | 8.98M | 7.08M | 7.69M | 6.83M | 7.8M | 6.32M | 7.69M | 10.42M | 8.8M | 8.95M | 7.85M | 7.37M | 6.32M | 5.85M | 8.06M | 8.19M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | 447K | 729K | 1.12M | 1.53M | 594K | 358K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 95K | 127K | 618K | 1M | 1.52M | 2.07M | 1.27M | 1.94M | 1.94M | 2.29M | 2.67M | 2.92M | 3.26M | 3.93M | 3.62M | 3.77M | 4M | 4.18M |
Total Liabilities | 8.62M | 11.03M | 9.6M | 8.08M | 9.21M | 8.9M | 9.07M | 8.26M | 9.63M | 12.71M | 11.47M | 11.87M | 11.11M | 11.3M | 9.94M | 9.61M | 12.06M | 12.37M |
Total Debt | 577K | 1.77M | 720K | 841K | 962K | 1.12M | 1.27M | 2.89M | 3.29M | 3.68M | 4.09M | 4.38M | 4.74M | 5.56M | 5.08M | 5.5M | 6.04M | 6.48M |
Common Stock | 16K | 15K | 14K | 14K | 14K | 13K | 13K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K |
Retained Earnings | -232.4M | -229.5M | -226.64M | -223.66M | -220.96M | -218.41M | -215.01M | -209.44M | -208.21M | -202.88M | -197.82M | -192.8M | -185.94M | -178.9M | -173.54M | -167.35M | -162.02M | -155.75M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
Shareholders Equity | -6.06M | -7.46M | -7.76M | -6.06M | -3.53M | -5.55M | -4.86M | -2.58M | -3.88M | -4.84M | -3.02M | 1.39M | 7.85M | 14.49M | 19.34M | 24.93M | 30.17M | 36.2M |
Total Investments | n/a | 182K | 184K | 181K | 179K | 182K | 185K | 196K | 202K | 206K | 2.21M | 3.25M | 3.24M | 3.25M | 3.24M | 2.11M | 4.05M | 4.11M |